{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-004004","form_type":"8-K","ticker":"OCEA","cik":"0001869974","company_name":"Ocean Biomedical, Inc.","filed_at":"2023-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.283748+00:00","generated_at":"2026-06-19T21:02:21.459288+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Ocean Biomedical awarded multiple patents for CHI3L1 antibody cancer therapies; deal with Aesther SPAC pending","bullets":["Dr. Jack A. Elias granted patents for mono-specific and bispecific antibodies targeting CHI3L1 to suppress multiple cancers.","Antibodies cover CHI3L1 alone, CHI3L1/PD-1 bispecific, and CHI3L1/CTLA4 bispecific.","Technology described as 'master regulator' of immune checkpoint pathways; shown to control lung cancer in murine models.","Ocean Biomedical expected to list on Nasdaq under OCEA/OCEAW after business combination with Aesther (AEHA).","Patents cover prostate, colon, ovarian, breast, lung cancers, glioblastoma, melanoma, etc."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-004004","json":"https://secwatch.observer/filing/0001493152-23-004004.json","markdown":"https://secwatch.observer/filing/0001493152-23-004004.md","text":"https://secwatch.observer/filing/0001493152-23-004004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1869974/000149315223004004/0001493152-23-004004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1869974/000149315223004004/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T21:02:21.459288+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}